Therapeutic Observation of Octreotide in Treatment of Malignant Bowel Obstruction
Peng Dai
Abstract
Peng Dai
Abstract
Objective:To investigate the effect of octreotide in treatment of malignant bowel obstruction.Methods:Forty-eight patients with malignant bowel obstruction without surgical indication were randomly divided into an octreotide group(n=25) and a control group(n=23).The two groups were treated with traditional treatment of fasting,gastrointestinal decompression,supplementing fluid and correcting water electrolysis balance.Based on the traditional treatment,the octreotide group was injected octreotide 0.2 mg hypodermically(once every 6 h or 8 h) for 3 to 14 days continually.Results:The symptom remission rate in the octreotide group was 80%,the average anal exhaust time was 4.7 days and the incidence of side effect was 12 %.The symptom remission rate in the control group was 27%,the average anal exhaust time was 7 days and the incidence of side effect was 43.5%.Conclusion:The effect of octreotide is content in treatment of malignant bowel obstruction and it could reverse bowel obstruction in the early stage of malignant bowel obstruction.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To investigate the effect of octreotide in treatment of malignant bowel obstruction.Methods:Forty-eight patients with malignant bowel obstruction without surgical indication were randomly divided into an octreotide group(n=25) and a control group(n=23).The two groups were treated with traditional treatment of fasting,gastrointestinal decompression,supplementing fluid and correcting water electrolysis balance.Based on the traditional treatment,the octreotide group was injected octreotide 0.2 mg hypodermically(once every 6 h or 8 h) for 3 to 14 days continually.Results:The symptom remission rate in the octreotide group was 80%,the average anal exhaust time was 4.7 days and the incidence of side effect was 12 %.The symptom remission rate in the control group was 27%,the average anal exhaust time was 7 days and the incidence of side effect was 43.5%.Conclusion:The effect of octreotide is content in treatment of malignant bowel obstruction and it could reverse bowel obstruction in the early stage of malignant bowel obstruction.
Key concepts: Medicine, Octreotide, Bowel obstruction, Gastroenterology, Incidence (geometry), Surgery, Decompression, Internal medicine